Long term responders to palliative chemotherapy for advanced biliary tract cancer.
Doherty, M McNamara, Mairéad G Aneja, P McInerney, E Moignard, S Horgan, A Jiang, H Panzarella, T Jang, R Dhani, N
Doherty, M
McNamara, Mairéad G
Aneja, P
McInerney, E
Moignard, S
Horgan, A
Jiang, H
Panzarella, T
Jang, R
Dhani, N
Citations
Altmetric:
Abstract
Patients with advanced biliary tract cancer (BTC) are often treated with palliative chemotherapy (PC). Standard PC since 2010 is a cisplatin/gemcitabine doublet, with median overall survival (OS) of 11.7 months from the ABC-02 trial. Prior to this, our institutional standard was gemcitabine and fluoropyrimidine. The ABC-02 study used 8 cycles of PC as standard with treatment stopped even in the absence of disease progression, but some patients may benefit from continuing PC longer than 8 cycles.
Description
Date
2017-04
Publisher
Collections
Keywords
Type
Article
Citation
Long term responders to palliative chemotherapy for advanced biliary tract cancer. 2017, 8 (2):352-360 J Gastrointest Oncol